Investigation of Cyperus Rotundus Root Extract on Diabetic Complications in Rats with Alloxan-Induced Diabetes

Background and Introduction: The prevalence of hyperglycemic diseases known collectively as diabetes has reached epidemic proportions in the current century. Diabetics are particularly vulnerable to infections, which can have devastating health consequences. The purpose of this research was to examine the effects of an aqueous extract of Cyperus rotundus roots on diabetic complications in rats with diabetes caused by Alloxan. Martial and Methods: Specifically: Alloxan monohydrate, Borosilicate, and a diagnostic kit. Specifically: a diagnostic kit, a phrase, or a paraphrase. Centrifuge Micropippet, Glucose check monitoring device, electronic digital scales, EDDY's Hot plate analgesometer MK-11, and the Biofuse pico. All chemicals employed were of the AR grade variety, including the alloxan monohydrate, metformin, chloroform, diethyl ether, and ethyl ether.Results: No deaths or toxicity symptoms were observed in the AECR acute toxicity test in mice, indicating that the extract was well tolerated and the test doses were safe in the animals. The effect of AECR on fasting blood glucose level in alloxan-induced diabetic rats was measured using an auto analyzer glucose kit to determine the compound's antidiabetic activity. The plasma or blood glucose level is measured after an individual has fasted as part of a carbohydrate metabolic test. The hormone glucagon is secreted into the bloodstream during fasting to facilitate the catabolic release of glucose. Conclusion: The results show that in alloxan-induced diabetic rats, the oral administration of an aqueous extract of Cyperus rotundus exhibited neuroprotective, nephroprotective, and hepatoprotective activities by increasing insulin production and decreasing glucogan production and an SGOT snd SGPT level

Role of the Rosa canina L. leaf extract as an antidiarrheal drug in rodents

Objectives: The objective of the study was to investigate the effect of the leaf extract of Rosa canina L. against experimental diarrhea induced by castor oil in rodents. Materials and Methods: The methanol extract of Rosa canina L. (30 and 60 mg/kg body weight) was administered orally to two groups of mice (five animals per group) in order to evaluate the activity of the extract against the castor oil-induced diarrhea model in mice. Two other groups received normal saline and diphenoxylate (5 mg/kg) as positive control. The effect of the extract on intestinal transit and castor oil-induced intestinal fluid accumulation (enteropooling) was assessed. The effects of the extract on the isolated rabbit jejunum and on the isolated rat ileum were studied. Results: The preliminary phytochemical screening of the leaf extract of Rosa Canina L. revealed the presence of alkaloids, flavonoids, glycosides, saponins, and volatile oil. Intraperitoneal LD50 of the extract was found to be 455.19 ± 23 mg/kg in mice. The antidiarrheal effect of the methanolic extract exhibited a concentration-dependent inhibition of the spontaneous pendular movement of the isolated rabbit jejunum and inhibited acetylcholine-induced contraction of the rat ileum. A dose-dependent decrease in gastrointestinal transit was observed with extracts (30 and 60 mg/kg), which also protected mice against castor oil-induced diarrhea and castor oil-induced fluid accumulation, respectively. Conclusions: The presence of some of the phytochemicals in the leaf extract may be responsible for the observed effects, and also the basis for its use in traditional medicine as an antidiarrheal drug

Role of the Rosa canina L. leaf extract as an antidiarrheal drug in rodents

Objectives: The objective of the study was to investigate the effect of the leaf extract of Rosa canina L. against experimental diarrhea induced by castor oil in rodents. Materials and Methods: The methanol extract of Rosa canina L. (30 and 60 mg/kg body weight) was administered orally to two groups of mice (five animals per group) in order to evaluate the activity of the extract against the castor oil-induced diarrhea model in mice. Two other groups received normal saline and diphenoxylate (5 mg/kg) as positive control. The effect of the extract on intestinal transit and castor oil-induced intestinal fluid accumulation (enteropooling) was assessed. The effects of the extract on the isolated rabbit jejunum and on the isolated rat ileum were studied. Results: The preliminary phytochemical screening of the leaf extract of Rosa Canina L. revealed the presence of alkaloids, flavonoids, glycosides, saponins, and volatile oil. Intraperitoneal LD50 of the extract was found to be 455.19 ± 23 mg/kg in mice. The antidiarrheal effect of the methanolic extract exhibited a concentration-dependent inhibition of the spontaneous pendular movement of the isolated rabbit jejunum and inhibited acetylcholine-induced contraction of the rat ileum. A dose-dependent decrease in gastrointestinal transit was observed with extracts (30 and 60 mg/kg), which also protected mice against castor oil-induced diarrhea and castor oil-induced fluid accumulation, respectively. Conclusions: The presence of some of the phytochemicals in the leaf extract may be responsible for the observed effects, and also the basis for its use in traditional medicine as an antidiarrheal drug

Pharmacological effects of aqueous–ethanolic extract of Hibiscus rosasinensis on volume and acidity of stimulated gastric secretion

ObjectiveTo explore the effects of extract of Hibiscus rosasinensis (H. rosasinensis) on the volume, free and total acidity of gastric secretion induced by carbachol.MethodsAnimals were kept on fasting for 48 h, then the pylorus of each animal was ligated. They were randomly divided into 5 groups and treated by carbachol at 600 μg/kg. Then animals in group II – V were treated by H. rosasinensis extract at 250 and 500 mg/kg body weight, cimetidine at 2.5 mg/kg and verapamil at 10 mg/kg body weight intraperitoneally, respectively. The volume, free and total acidity of gastric secretion were observed and compared.ResultsIt was found that the extract significantly reduced the volume, free and total acidity of gastric secretion (P<0.01). These reductions were comparable to cimetidine and verapamil. And the reduction in the volume and free acidity were more significant in cimetidine and verapamil treated group indicating that cimetidine and verapamil were more effective.ConclusionsThe extract of H. rosasinensis can reduced the volume, free and total acidity of gastric secretion, and can be used effectively in the treatment of peptic ulcer

Screening of Manilkara zapota (L) P. Royen stem bark ethanolic extract for in vitro α-glucosidase inhibition, preliminary antidiabetic effects, and improvement of diabetes and its complications in alloxan-induced diabetes in Wistar rats

Abstract Background A perusal of the literature suggested that Manilkara zapota (L.) P. Royen stem bark (MZSB) is enriched with several bioactive phytoconstituents but had not been yet screened for its in vitro and in vivo antidiabetic potentials. Thus, the present study aimed to investigate the effects of 70% ethanolic extract of Manilkara zapota (L) P. Royen stem bark (EMZSB) in DPPH- and H2O2-scavenging assay, in vitro α-glucosidase inhibition assay, ameliorating diabetes and its complications in alloxan-induced diabetes in Wistar rats. Results With a maximum extractive yield of 9.16% w/w, EMZSB has shown the presence of various phytochemicals like flavonoids, phenolic compounds, tannins, anthraquinone glycosides, steroids, terpenoids, and alkaloids. EMZSB has elucidated a considerable in vitro free radical scavenging potential by DPPH and H2O2 assays when compared with absolute ethanolic extract of Manilkara zapota (L) P. Royen stem bark (AEMZSB), while ascorbic acid was taken as the standard. Further, EMZSB demonstrated high in vitro α-glucosidase enzyme inhibition potential (IC50 = 119.79 ± 1.52 µg/mL) than AEMZSB (IC50 = 129.92 ± 2.29 µg/mL) with a significant difference (p &lt; 0.01), when acarbose was taken as reference inhibitor (IC50 = 86.43 ± 1.26 µg/mL). During acute toxicity studies EMZSB was safe up to 2000 mg kg−1 doses while, found causing moribund status followed by mortality in mice at 3000 mg kg−1 and above doses. A preliminary antidiabetic study with EMZSB-250 mg kg−1 in normal rats showed no sign of hypoglycemia; however, a dose-dependent antihyperglycemic effects were observed in oral glucose tolerance test in glucose-loaded rats. In vivo assessment with EMZSB-250 mg kg−1 in alloxan-induced rats demonstrated significant blood glucose-lowering effects with perfection in serum lipid profile, body weight enhancement, cardiovascular risk indices, nephroprotective effects, augmentation in liver glycogen content, and histopathological evidence of normal architecture of kidneys with no marks for nephritis. Conclusions EMZSB-250 showed significant antidiabetic effects and ameliorated diabetic complications by improving glycemic control and accompanying biochemical alteration. </jats:sec